By the time our preclinical trials are complete they could well be 10th confirmation. The major reason for running our own trials is to answer questions specific to the clinical programs we want to run - the issue now is not does Bisantrene work, but will it work in the particular cancer types we are using for our proof of principle studies.
Ann: Second independent study shows Bisantrene inhibits FTO, page-46
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
